GLUT1 expression is correlated with EMT markers, including E-cadherin and vimentin, and it is accompanied by increased glucose uptake during TGF-β-induced EMT in breast cancer cells [76, 78]. This evidence concerns the gene SLC2A1 and breast cancer.